Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04148937
Brief Title: A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

First Submitted : October 31, 2019
First Submitted that Met QC Criteria : November 1, 2019
First Posted : November 4, 2019

Last Update Submitted that Met QC Criteria : December 2, 2019
Last Update Posted : December 3, 2019